Orphan and rare disease marketers: are you armed for success?

March 8, 2010
Business Services, Sales and Marketing Orphan

Many marketers are currently unfamiliar with the specific approaches required in orphan and rare disease (ORD) brands, but will need …

Adventis Health

Adventis Health restructures

March 8, 2010
Medical Communications Adventis, medical communications

Adventis Health has restructured its client service teams in a move the coms agency says will allow it to better …

Pfizer Facebook

Digital Pharma: Byte-sized roundup

March 8, 2010
Medical Communications Pfizer, digital pharma, digital pharma pfizer

A roundup of digital developments, including Pfizer’s new Facebook page and beta-phase science blog, Lundbeck, BMS, Baxter and Janssen-Cilag on …

Stricter monitoring for UK supply chain

March 5, 2010
parallel trade, supply chain

New measures to ensure that the UK doesn’t suffer from shortages of prescription medicines have been announced by the government. …

Blood clot

Phase III success for apixaban

March 5, 2010
Research and Development BMS, Pfizer, VTE, apixaban

Pfizer and Bristol-Myers Squibb’s apixaban has shown promising results in a late-stage head-to-head trial with Sanofi-Aventis’ Lovenox. The oral anti-coagulant …

MabThera

Roche cancer drug gets NICE thumbs up

March 5, 2010
Sales and Marketing MabThera, Roche

NICE has recommended Roche’s MabThera to treat patients with the most common form of leukaemia, relapsed or refractory chronic lymphocytic …

FDA encourages cell-based vaccine production

March 5, 2010
Manufacturing and Production h1n1, swine flu

The US Food and Drug Administration has issued a new guidance document designed to help encourage the adoption of cell-based …

Sudler & Hennessey London expands

March 5, 2010
Medical Communications Sudler & Hennessey, appointments, medical communications

Sudler & Hennessey London has added ten new members to its team, expanding its account handling and creative departments. Group …

NICE asks Roche for RoActemra cost data

March 5, 2010
Sales and Marketing RoActemra, Roche

Roche’s attempts to secure NICE approval for rheumatoid arthritis drug RoActemra have hit another hurdle. NICE’s independent appraisal committee has …

Merck appoints Bridgette Heller

March 5, 2010
Sales and Marketing Merck, appointment, consumer healthcare, sales and marketing

Bridgette Heller has joined Merck & Co as executive vice president and president, consumer health care. She moves to Merck …

FPA logo

Just teams up with sexual health charity

March 5, 2010
Medical Communications FPA, charity, contraception, just health pr

Just Health PR is providing PR support for the launch of a new UK consumer book on contraception from sexual …

Kantar Health promotes Ceri Thomas

March 4, 2010
Sales and Marketing Kantar Health, appointment, sales and marketing

Ceri Thomas has been promoted to head of global marketing at healthcare consultancy and marketing insights company Kantar Health. In …

Pfizer suffers Alzheimer’s setback

March 4, 2010
Research and Development Alzheimer's, Medivation, Pfizer

Pfizer has suffered a big setback with the oral Alzheimer’s disease treatment it is developing with biotech outfit Medivation. Investigational …

HCA report

HCA: Five years of change in healthcare communications

March 4, 2010
Medical Communications HCA, industry reputation

In 2005 the Healthcare Communications Association (HCA) conducted its first ever benchmarking survey, exploring trends in the provision of communications …

Andreotti

Lamberto Andreotti new head of Bristol-Myers Squibb

March 4, 2010
Research and Development, Sales and Marketing BMS, appointment, research and development, sales and marketing

Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will …

Mario Nacinovich

Axon expands in the US

March 4, 2010
Medical Communications Axon, medical communications

Surrey, UK-based Axon Communications has appointed Mario Nacinovich as managing director of its new US operations. Nacinovich will be based …

Stem cell therapy helps diabetes limb problems

March 3, 2010
Research and Development ReNeuron, diabetes, stem cell

Stem cell therapy aimed at restoring blood flow to damaged limbs in people with diabetes has shown promise, according to UK …

UCB

Generic Keppra hits UCB sales

March 3, 2010
Sales and Marketing 2009 financials, Keppra, UCB

UCB’s sales fell 13% in 2009 as the pharma company faced the first full year of generic competition in the …

Funds keep Archimedes Pharma buoyant

March 3, 2010
Research and Development Archimedes, funding

Archimedes Pharma has completed the biggest fundraising by a private European biotech in 15 years by securing £65 million. The …

Dementia strategy

Awareness push for dementia

March 3, 2010
dementia, disease awareness campaigns

The government’s offensive on dementia has continued with a new awareness campaign called Living Well, which aims to break down …

The Gateway to Local Adoption Series

Latest content